Special requirements for toxicity testing of oral compounds administered continuously or cyclically.
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects; D002582:Cervix Mucus / Q000187:drug effects; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology / Q000633:toxicity; D003864:Depression, Chemical; D004285:Dogs; D004341:Drug Evaluation / Q000592:standards; D004353:Drug Evaluation, Preclinical / Q000592:standards; D004717:Endometrium / Q000187:drug effects; D005260:Female; D000882:Haplorhini; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D008099:Liver / Q000187:drug effects; D051379:Mice; D010060:Ovulation / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D013268:Stimulation, Chemical; D013997:Time Factors; D014621:Vagina / Q000187:drug effects
D003276:Contraceptives, Oral